CBT review finds symptom improvements in subclinical depression
Pooled trials reported improvements in depressive and anxiety symptoms after treatment and at follow-up. Quality of life showed no notable improvement, and prevention findings had limitations.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Cognitive behavioral therapy was associated with improved depressive and anxiety symptoms in trials involving people with subclinical depression. Improvements were reported after treatment and at follow-up, but quality of life did not show a notable benefit. A lower risk of progression to major depression was also reported, with evidence limited by self-reported data.
Most studies came from Europe, limiting generalizability. Self-reporting weakened the prevention evidence, and comparisons across therapy types and components were limited. The abstract does not specify follow-up lengths or the control conditions used.
Symptoms and prevention are separate questions
The review asked both whether therapy reduced existing symptoms and whether it helped prevent progression to major depression. Improvement in symptom scores does not automatically establish prevention; the authors assessed that outcome separately and noted weaker evidence.
What persistence means here
The reported symptom differences remained at follow-up, but the abstract does not say how much time had passed. This supports a narrower conclusion than claiming benefits last for a particular number of months or years.
The original publication
Long-Term Effect of Cognitive Behavioral Therapy in Managing Subclinical Depression: A Systematic Review and Meta-Analysis.
Chan RCF, Chen M, Chan JLM et al.
Depress Anxiety · 2025
- PubMed ID
- 40861245
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.